Environmental Responsibility and Biopharmaceutical Companies: Developing a Competitive Strategy
Corporate environmental responsibility (CER) is now on the corporate and political agenda in China. The objective of this study is to determine the relevance of environmental aspects for China biopharmaceutical companies. This paper presents a new perspective which calls for an integration of CER into the business strategy as a source of competitive advantages in the biopharmaceutical companies. We also introduce an Internal Responsibility System (IRS) to meet company’s environmental responsibilities.
CER Competitivestrategy Biopharmaceuticalcompanies IRS
Wei Li Ruixiang Yu
School of Economy and ManagementChina University of GeosciencesWuhan, China, 430074
国际会议
广州
英文
1-4
2011-05-13(万方平台首次上网日期,不代表论文的发表时间)